מקדם חוב לטווח ארוך להון mediwound.com (MDWD)

Current price action for MediWound Ltd. (MDWD) reflects levels of 0.25, while the company adheres to basic environmental standards in the development of burn therapy products. Financial results are constrained by slow approvals for new products and a reliance on government contracts. Business stability is ensured by a high-tech Israeli plant featuring redundant production lines and an independent power supply.

Developing automated enzymatic wound cleansing systems requires significant R&D and equipment capital expenditures, which are often accompanied by the procurement of long-term financing. By analyzing the share of long-term liabilities in capital, an investor assesses the ratio of loans with maturities exceeding one year to equity, determining the financial stability of MediWound Ltd. (MDWD) and the risks of over-leverage during business scaling.